男性原发性尿道癌的临床分析  

Primary male urethral cancer:Management and prognosis

作　　者：朱晓斐[1] 张凯[1] 金杰[1] 黄炳伟[1] 李森[1] 林健[1] 

机构地区：[1]北京大学第一医院泌尿外科,北京100034

出　　处：《中华男科学杂志》2012年第7期615-618,共4页National Journal of Andrology

摘　　要：目的:探讨男性原发性尿道癌的治疗方法和预后评估。方法:回顾了从2001年至2011年10年之间在我院治疗的男性原发性尿道癌患者3例,并对其进行随访,了解复发和生存情况。结果:3例男性原发性尿道癌患者,都进行了辅助性放化疗。其中2例行远端尿道切除,1例未行手术。2例患者发生转移,1例患者死亡。结论:男性原发性尿道癌是一种少见恶性肿瘤,预后较差。治疗方式以根治性手术为主,对于晚期患者可以采用手术、放疗和化疗相结合的综合治疗方案。Objective： To further investigate the management and prognosis of primary urethral cancer in male. Methods： We treated 3 cases of primary urethral cancer from 2001 to 2011 and followed them up for recurrence and survival. Results： The 3 male patients all received adjuvant radiotherapy and/or chemotherapy, and 2 of them were treated by distal urethrectomy, while the other underwent no surgery. Follow-up visits revealed 2 cases of metastasis and 1 case of death. Conclusion ： Primary cancer of the male urethra is a rare malignancy with poor prognosis, for which radical resection is the main treatment method. Those in the relatively advanced stage can be treated by a combined method of surgery, radiotherapy and chemotherapy.

关 键 词：原发性尿道癌 治疗 预后 

分 类 号：R737.15[医药卫生—肿瘤]